Development of a protocol for detection of SARS-CoV-2 in sputum and endotracheal aspirates using Cepheid Xpert Xpress SARS-CoV-2
- PMID: 33490871
- PMCID: PMC7818244
- DOI: 10.1099/acmi.0.000176
Development of a protocol for detection of SARS-CoV-2 in sputum and endotracheal aspirates using Cepheid Xpert Xpress SARS-CoV-2
Abstract
Sputum and endotracheal aspirates (ETs) are not among the vendor-approved specimens for the Cepheid Xpert SARS-CoV-2 assay. However, they are the common lower respiratory tract specimens submitted for laboratory diagnosis. Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in lower respiratory tract samples is required for the discharge of patients from coronavirus disease (COVID) units at some institutions. We developed a protocol used for testing unliquified viscous sputum or tracheal aspirate with the Cepheid Xpert SARS-CoV-2 assay.
Keywords: sputum; Cepheid Xpert Xpress; SARS-CoV-2; endotracheal aspirate; rapid detection.
© 2020 The Authors.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Similar articles
-
Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.Microbiol Spectr. 2022 Jun 29;10(3):e0039922. doi: 10.1128/spectrum.00399-22. Epub 2022 May 18. Microbiol Spectr. 2022. PMID: 35583359 Free PMC article.
-
Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay.J Clin Virol. 2020 Oct;131:104593. doi: 10.1016/j.jcv.2020.104593. Epub 2020 Aug 16. J Clin Virol. 2020. PMID: 32823131 Free PMC article.
-
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.J Clin Microbiol. 2021 Feb 18;59(3):e02955-20. doi: 10.1128/JCM.02955-20. Print 2021 Feb 18. J Clin Microbiol. 2021. PMID: 33298613 Free PMC article.
-
Point-of-care testing for the detection of SARS-CoV-2: a systematic review and meta-analysis.Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):503-517. doi: 10.26355/eurrev_202101_24422. Eur Rev Med Pharmacol Sci. 2021. PMID: 33506942
-
SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis.EBioMedicine. 2020 Sep;59:102903. doi: 10.1016/j.ebiom.2020.102903. Epub 2020 Jul 24. EBioMedicine. 2020. PMID: 32718896 Free PMC article.
Cited by
-
Detection of SARS-CoV-2 Infection in Gargle, Spit, and Sputum Specimens.Microbiol Spectr. 2021 Sep 3;9(1):e0003521. doi: 10.1128/Spectrum.00035-21. Epub 2021 Aug 25. Microbiol Spectr. 2021. PMID: 34431686 Free PMC article.
-
SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond.Front Cell Infect Microbiol. 2022 Mar 23;12:799678. doi: 10.3389/fcimb.2022.799678. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35402302 Free PMC article. Review.
-
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780. Cochrane Database Syst Rev. 2024. PMID: 39679851 Free PMC article.
References
-
- Cepheid Cepheid Xpert Xpress SARS-CoV-2 Instructions for Use. April 2020(Rev C) 3260
-
- FDA Statistical guidance on reporting results from studies evaluating diagnostic tests. 2007.
LinkOut - more resources
Full Text Sources
Miscellaneous